盐酸莫西沙星联合康妇消炎栓治疗盆腔炎疗效观察

目的探讨盐酸莫西沙星联合康妇消炎栓治疗盆腔炎的临床疗效。方法选取佛山市顺德区妇幼保健院2010年9月～2012年3月收治的78例盆腔炎患者为研究对象,将所有患者随机分成观察组与对照组,每组各39例,观察对比两组的临床疗效及不良反应发生率,治疗一个疗程后观察包块吸收率、并发症发生率、复发率及手术率。结果观察组总有效率为94.9%;对照组总有效率为82.0%,两组疗效比较差异有统计学意义(P<0.05)。结论盐酸莫西沙星联合康妇消炎栓治疗盆腔炎临床疗效理想,明显优于单纯使用盐酸莫西沙星治疗。

Objective Observation of moxifloxacin hydrochloride combined with Kangfu Antiphlogistic Suppository in the treatment of pelvic inflammatory disease clinical curative effect. Methods From September 2010 to March 2012, 78 patients with pelvic inflammation, were randomLy divided into observation group and control group, 39 cases in each, were compared between two groups of curative effect and adverse reaction rates, after a course of treatment, the rate of mass absorption rate, complication rate, recurrence rate, the rate of operation. Results The total effective rate in the observation group was 94.9%; the control group in the total efficiency of 82.0%, two groups had significant difference （P0.05）, there was statistical significance. Conclusion Moxifloxacin hydrochloride combined with Kangfu Antiphlogistic Suppository in the treatment of pelvic inflammatory disease with clinical efficacy of ideal, is superior to the single use of moxifloxacin hydrochloride treatment.